Topic: Package Insert

Dr. Fleming points out that COVID-19 vaccine package inserts are intentionally left blank, depriving doctors of the information needed for true informed consent. Furthermore, there are currently no specific CPT codes for doctors to record adverse reactions to COVID vaccines, which may result in a lack of accurate historical data on vaccine injuries.

Dr. Jane Ruby, drawing on 20 years of pharmaceutical experience, analyzes the Pfizer "Comirnaty" package insert and clinical trial protocols. She argues that the trials are ongoing until 2023 and that the FDA approval process was a "sham" that bypassed traditional safety stages. Ruby highlights the lack of data for pregnant women and the absence of drug-drug interaction studies in the current vaccine rollout.

Dr. Ruby and Stu Peters discuss the alleged sabotage of the Trump administration by Anthony Fauci and Deborah Birx. They claim that the FDA's approval of "Comirnaty" is a "phony psyop" and that the package inserts for the drug lack the standard data required for a legitimate regulatory process.

Dr. Jane Ruby joins Stu Peters to clarify the confusion surrounding the FDA's approval of the Pfizer vaccine. She explains that while "Comirnaty" received approval, it is being used interchangeably with the existing BioNTech formulation under Emergency Use Authorization. Ruby points out that the "package insert" for Comirnaty is missing critical risk disclosures required for legally approved drugs.

Peters and Ruby discuss the "blank" package inserts found in vaccine shipments. Dr. Ruby explains that these inserts are legal documents that should contain safety and efficacy data, and their absence indicates a total lack of transparency regarding the contents of the injections.